|
Market Closed -
Nasdaq
16:00:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 81.86 USD | -0.56% |
|
-0.63% | +0.94% |
| 08-06 | Barrington Upgrades LeMaitre Vascular to Outperform From Market Perform, Price Target is $95 | MT |
| 08-05 | Barrington Downgrades LeMaitre Vascular to Market Perform From Outperform | MT |
Company Valuation: LeMaitre Vascular, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,097 | 1,012 | 1,264 | 2,072 | 1,840 | 1,872 | - | - |
| Change | - | -7.7% | 24.81% | 63.94% | -11.19% | 1.75% | - | - |
| Enterprise Value (EV) 1 | 1,097 | 1,012 | 1,264 | 2,072 | 1,840 | 1,632 | 1,572 | 1,872 |
| Change | - | -7.7% | 24.81% | 63.94% | -11.19% | -11.32% | -3.67% | 19.11% |
| P/E | 40.2x | 49.5x | 42.4x | 47.7x | 32.2x | 28.5x | 25.8x | 24x |
| PBR | - | - | - | - | - | 4.26x | 3.69x | - |
| PEG | - | -1.9x | 1x | 1.1x | 1.1x | 2x | 2.4x | 3.26x |
| Capitalization / Revenue | 7.1x | 6.26x | 6.53x | 9.42x | 7.37x | 6.77x | 6.18x | 5.67x |
| EV / Revenue | 7.1x | 6.26x | 6.53x | 9.42x | 7.37x | 5.9x | 5.19x | 5.67x |
| EV / EBITDA | 24x | 25.9x | 27.5x | 33.6x | 24.8x | 18.7x | 16.1x | 17.4x |
| EV / EBIT | 30.1x | 33.8x | 34.4x | 39.6x | 27.1x | 21.1x | 18x | 19.5x |
| EV / FCF | 36.3x | 45.7x | 42.9x | 55.7x | 24.7x | 26.2x | 20x | 23x |
| FCF Yield | 2.75% | 2.19% | 2.33% | 1.79% | 4.05% | 3.82% | 5.01% | 4.35% |
| Dividend per Share 2 | 0.44 | 0.5 | 0.56 | 0.64 | 0.8 | 1 | 1.12 | - |
| Rate of return | 0.88% | 1.09% | 0.99% | 0.69% | 0.99% | 1.22% | 1.37% | - |
| EPS 2 | 1.25 | 0.93 | 1.34 | 1.93 | 2.52 | 2.872 | 3.179 | 3.412 |
| Distribution rate | 35.2% | 53.8% | 41.8% | 33.2% | 31.7% | 34.8% | 35.2% | - |
| Net sales 1 | 154.4 | 161.7 | 193.5 | 219.9 | 249.6 | 276.5 | 302.9 | 330 |
| EBITDA 1 | 45.78 | 39.04 | 45.91 | 61.74 | 74.31 | 87.25 | 97.82 | 107.4 |
| EBIT 1 | 36.42 | 29.94 | 36.71 | 52.26 | 67.91 | 77.3 | 87.26 | 95.88 |
| Net income 1 | 26.91 | 20.64 | 30.1 | 44.04 | 57.73 | 66.71 | 74.29 | 81.23 |
| Net Debt 1 | - | - | - | - | - | -240.5 | -300.4 | - |
| Reference price 2 | 50.23 | 46.02 | 56.76 | 92.14 | 81.10 | 81.86 | 81.86 | 81.86 |
| Nbr of stocks (in thousands) | 21,838 | 22,001 | 22,263 | 22,484 | 22,686 | 22,869 | - | - |
| Announcement Date | 2/24/22 | 2/23/23 | 2/27/24 | 2/27/25 | 2/25/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 28.5x | 5.9x | 18.7x | 1.22% | 1.87B | |
| 31.34x | 5.52x | 21.17x | 0.29% | 233B | |
| 36.92x | 6.61x | 20.97x | 0.65% | 154B | |
| 41.55x | 10.81x | 23.9x | -.--% | 134B | |
| 18.8x | 3.82x | 12.41x | -.--% | 73B | |
| 19.92x | 2.38x | 11.91x | 2.56% | 52.24B | |
| 35.48x | 7.12x | 22.52x | -.--% | 51.75B | |
| 30.92x | 6.16x | 21.06x | 0.65% | 44.91B | |
| 71.9x | 6.86x | 20.86x | -.--% | 40.35B | |
| 16.02x | 1.83x | 10.25x | 0.21% | 33.8B | |
| Average | 33.13x | 5.70x | 18.37x | 0.56% | 81.83B | |
| Weighted average by Cap. | 33.81x | 6.29x | 19.81x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- LMAT Stock
- Valuation LeMaitre Vascular, Inc.
Select your edition
All financial news and data tailored to specific country editions
